Huntington's Disease - Coenzyme Q10 Study
Coenzyme Q10 in Huntington's Disease (HD) Protocol No.:2CARE-01.00
Protocol ID
07-124
Protocol Description
The purpose of this study is to assess the effect of Coenzyme Q10 (CoQ), a marketed nutritional supplement, on slowing the worsening of Huntington's Disease (HD) symptoms. We will also assess the safety and the acceptability of CoQ in long-term use.
CoQ is being studied, as an investigational drug at a higher dose than is currently available for purchase.
Eligibility Criteria
Patients with Huntington's disease (HD)
Primary Investigator(s)
- Andrew Feigin, MD